AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade governance, validation, and human oversight isn't a strategy. It's a risk.
Philip Raeth
Advertisement
Philip Raeth is Managing Director at Palleos.
Articles by Philip Raeth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How Much of the Community Participation Gap Is About Infrastructure, Not Willingness?
2
Closing the Medical Writing Capacity Gap: Why Training Beats Technology
3
Measuring What Matters: Realigning Clinical Endpoints with Patient Reality
4
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
5